Bulk Manufacturer of Controlled Substances Application: Chemic Laboratories, 34045 [2021-13671]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 121 / Monday, June 28, 2021 / Notices
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–859]
[Docket No. DEA–846]
Importer of Controlled Substances
Application: AMRI Rensselaer, Inc.
Bulk Manufacturer of Controlled
Substances Application: Chemic
Laboratories
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Drug Enforcement
Administration, Justice.
Chemic Laboratories, has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 27, 2021. Such persons
may also file a written request for a
hearing on the application on or before
August 27, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 30, 2021, Chemic
Laboratories, 480 Neponset Street,
Building 7, Canton, Massachusetts
02021–1971, applied to be registered as
a bulk manufacturer of the following
basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
khammond on DSKJM1Z7X2PROD with NOTICES
Psilocybin .....................
Psilocyn ........................
I
7437
7438
Schedule
I
I
I
The company plans to manufacture
small quantities of the listed controlled
substances for research and
development in preclinical studies for
sale to its customers. No other activities
for these drug codes are authorized for
this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–13671 Filed 6–25–21; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
17:39 Jun 25, 2021
Jkt 253001
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–13672 Filed 6–25–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
AMRI Rensselaer, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 28, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 28, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 20, 2021, AMRI
Rensselaer, Inc., 33 Riverside Avenue,
Rensselaer, New York 12144, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
Notice of application.
Controlled substance
Administration-approved or nonapproved finished dosage forms for
commercial sale.
AGENCY:
AGENCY:
ACTION:
34045
Controlled substance
Drug
code
Poppy Straw Concentrate ......
9670
Schedule
II
The company plans to import the
listed controlled substance to
manufacture a bulk controlled substance
for distribution to its customers.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
[OMB Number 1121–0292]
Agency Information Collection
Activities; Proposed Collection
Comments Requested; Extension of
Currently Approved Collection: Survey
of Sexual Victimization (SSV)
Bureau of Justice Statistics,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Office of Justice Programs,
Bureau of Justice Statistics, will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
was previously published in the Federal
Register, allowing a 60-day comment
period. Following publication of the 60day notice, the Bureau of Justice
Statistics received no substantive
comments.
SUMMARY:
Comments are encouraged and
will be accepted for an additional 30
days until July 28, 2021.
FOR FURTHER INFORMATION CONTACT:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
DATES:
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 86, Number 121 (Monday, June 28, 2021)]
[Notices]
[Page 34045]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13671]
[[Page 34045]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-846]
Bulk Manufacturer of Controlled Substances Application: Chemic
Laboratories
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Chemic Laboratories, has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 27, 2021.
Such persons may also file a written request for a hearing on the
application on or before August 27, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on April 30, 2021, Chemic Laboratories, 480 Neponset
Street, Building 7, Canton, Massachusetts 02021-1971, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Psilocybin............................. 7437 I
Psilocyn............................... 7438 I
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances for research and development in preclinical
studies for sale to its customers. No other activities for these drug
codes are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-13671 Filed 6-25-21; 8:45 am]
BILLING CODE P
